Psilocybin-assisted psychotherapy improved interpersonal sensitivity, hostility, obsession-compulsion, and somatization in ...

Silicon Valley has a long history with psychedelics, and some of its best-known leaders have partaken, including Steve Jobs ...

The psychedelic drugs market was valued at $0.7 billion in 2022 and is projected to reach $2.6 billion by 2032, growing at a CAGR of 13.4% from 2023 to 2032.

The connection between mental health disorders and their treatments is still a key focus for research. The multifaceted ...

BetterLife Pharma (TSE:BETR) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - ...

BETR-002, which is in preclinical and IND-enabling studies, is based on honokiol, the active anxiolytic ingredient of magnolia bark. BetterLife’s pending method of use and formulations patent covers ...

Joe McKay tried everything medicine had to offer for the blinding headaches that began in the months after 9/11, when the ...

More and more research is being done on psychedelics including LSD, psilocybin, and ketamine. Here's what we know and what we ...

Psychedelics and hallucinogens include a wide variety of substances, including LSD, psylocibin (mushrooms), MDMA (molly), ketamine, mescaline, DMT and more.

Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...

Standard treatments ease depression for a lot of people, but they don't work for everyone. At least 30% of those who try two or more antidepressants continue to have serious symptoms. That's ...